Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Kodiak Sciences Inc (KOD)

Kodiak Sciences Inc (KOD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kodiak Sciences Inc 1250 PAGE MILL ROAD PALO ALTO CA 94304 USA

www.kodiak.com Employees: 109 P: 650-281-0850

Sector:

Medical

Description:

Kodiak Sciences Inc. is a clinical stage biopharmaceutical company engaged in developing novel therapeutics to treat chronic, high-prevalence retinal diseases, which are the major causes of blindness. The company's proprietary antibody biopolymer conjugate (ABC) platform is designed to maintain potent and effective drug levels in ocular tissues for longer periods than the currently-marketed biologic medicines for treating retinal diseases.

Key Statistics

Overview:

Market Capitalization, $K 1,263,073
Enterprise Value, $K 1,095,003
Shares Outstanding, K 53,048
Annual Sales, $ 0 K
Annual Net Income, $ -176,210 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -61,460 K
EBIT, $ -223,110 K
EBITDA, $ -196,400 K
60-Month Beta 2.68
% of Insider Shareholders 45.90%
% of Institutional Shareholders 89.06%
Float, K 28,699
% Float 54.10%
Short Volume Ratio 0.41

Growth:

1-Year Return 184.47%
3-Year Return 244.08%
5-Year Return -15.25%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -168.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.16 on 11/13/25
Next Earnings Date 03/26/26
Earnings Per Share ttm -4.12
EPS Growth vs. Prev Qtr -12.62%
EPS Growth vs. Prev Year -38.10%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 5-1 on 02/23/22

KOD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -246.20%
Return-on-Assets % -78.44%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 53.80
Book Value/Share 0.45
Interest Coverage -1.90
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar